Log on / register
Feedback | Support | My details
Frequency of CHEK2*1100delC in New York breast cancer cases and controls.
Offit K, Pierce H, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson S, Yossepowitch O, Huang H, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N
BMC Med Genet 2003 Jan 15, 4:1
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


Research article    
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer
Margolin S, Eiberg H, Lindblom A, Bisgaard ML
BMC Cancer 2007, 7:163 (17 August 2007)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.
36%36%


Research article    
Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FBL, Schmidt MK, Klijn JGM, Russell NS, Van Leeuwen FE, Van 't Veer LJ
Breast Cancer Research 2007, 9:R26 (11 April 2007)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

3.
36%36%


Research article    
CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
Isinger A, Bhat M, Borg A, Nilbert M
BMC Cancer 2006, 6:64 (15 March 2006)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

4.
36%36%


Research article    
Frequency of CHEK2 mutations in a population based, casecontrol study of breast cancer in young women
Friedrichsen DM, Malone KE, Doody DR, Daling JR, Ostrander EA
Breast Cancer Res 2004, 6:R629-R635 (22 September 2004)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]


This article is also cited by a further 4 articles in PubMed Central

printer friendly 
to  [Help]

© 1999-2008 BioMed Central Ltd unless otherwise stated